Is Cerebrolysin used to treat autism?

Cerebrolysin is an adjunctive drug in the treatment of mild organic syndromes, including dementia. Available studies have demonstrated the following effects of Cerebrolysin: "In animal studies, Cerebrolysin directly affects neuronal and synaptic plasticity, improving the ability to learn. In cerebral ischaemia models, Cerebrolysin reduced the area of ischaemic necrosis, inhibited oedema, stabilised microcirculation, doubled survival and normalised neurological disorders associated with lesions and learning limitations."
In published studies, there are studies that show a decrease in the CARS (Childhood Autism Rating Scale) and a decrease in autistic traits, and in some patients a complete disappearance of the main autistic features, in people using cerebrolysin. The studies were conducted in children, on small groups of patients. Publications suggest the potential for the use of Cerebrolysin in the treatment of autism, although this indication is not included in the Summary of Product Characteristics.

I am attaching links to the publications:

https://pubmed.ncbi.nlm.nih.gov/29053124/

https://adc.bmj.com/content/104/Suppl_3/A321.2

https://www.academia.edu/download/61480905/The_use_of_cerebrolysin_and_citicoline_in_autism20191210-86329-1qdfdtg.pdf